Journal Mobile Options
Table of Contents
Vol. 57, No. 2, 2005
Issue release date: March–April 2005
Folia Phoniatr Logop 2005;57:111–118

Efficacy of Conservative Voice Treatment in Male-to-Female Transsexuals

Mészáros K. · Csokonai Vitéz L. · Szabolcs I. · Góth M. · Kovács L. · Görömbei Z. · Hacki T.
aDepartment of Ear, Nose and Throat Diseases and bDepartment of Medicine, Division of Endocrinology, National Medical Center, Budapest, Hungary; cDepartment of Phoniatrics and Pediatric Audiology, Department of ENT, University of Regensburg, Regensburg, Germany

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


A voice assessment was performed before and after conservative voice treatment in 3 male-to-female transsexuals and in 2 nontreated transsexuals serving as control persons. The characteristics studied were voice quality, habitual speaking pitch, vocal pitch range, vocal intensity range, maximum phonation time and ‘communicative impairment’, a subjective self-estimation by the patient. Based on these parameters the Friedrich dysphonia index (DI) was calculated. The habitual speaking pitch of the 3 transsexuals who had received voice treatment became female, in contrast to that of the nontreated transsexuals, which remained in the so-called ‘indifferent pitch range’. The DI of the treated patients was close to the normal value, in contrast to the DI of controls, which continued to be pathological. Even based on this small population, study results reflected the effectiveness of voice therapy in transsexuals.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Heinemann M: Hormone und Stimme. Leipzig, Barth, 1976, pp 7–181.
  2. Newman SR, Butler J, Hammond EH, Gray SD: Preliminary report on hormone receptors in the human vocal fold. J Voice 2000;14:72–81.
  3. Narbaitz R, Stumpf WE, Sar M: Estrogen target cells in the larynx: Autoradiographic studies with 3H-diethylstilbestrol in fetal mice. Horm Res 1980;12:113–117.
  4. Sassoon D, Segil N, Kelley D: Androgen-induced myogenesis and chondrogenesis in the larynx of Xenopus laevis. Dev Biol 1986;113:135–140.
  5. Tobias ML, Marin ML, Kelley DB: Temporal constraints on androgen directed laryngeal masculinization in Xenopus laevis. Dev Biol 1991;147:260–270.
  6. Boyd SK, Wissing KD, Heinsz JE, Prins GS: Androgen receptors and sexual dimorphism in the larynx of the bullfrog. Gen Comp Endocrinol 1999;113:59–68.
  7. Takahashi MM, Noumura T: Sexually dimorphic and laterally asymmetric development of the embryonic duck syrinx: Effect of estrogen on in vitro cell proliferation and chondrogenesis. Dev Biol 1987;121:417–422.
  8. Edwards CJ, Yamamoto K, Kikuyama S, Kelley DB: Prolactin opens the sensitive period for androgen regulation larynx-specific myosin heavy chain gene. J Neurobiol 1999;41:443–451.
  9. Abitbol J, Abitbol P, Abitbol B: Sex hormones and the female voice. J Voice 1999;13:424–426.
  10. Kahane JC: Growth of the human prepubertal and pubertal larynx. J Speech Hear Res 1982;25:446–455.
  11. Robertson JC, Kelley DB: Thyroid hormone controls the onset of androgen sensitivity in the developing larynx of Xenopus laevis. Dev Biol 1996;176:108–123.
  12. Böhme G: Sprach-, Sprech-, Stimm- und Schluckstörungen. Stuttgart, Fischer, 1997, vol I, pp 158–164.
  13. Wendler J, Seidner W, Kittel G, Eysholdt U: Lehrbuch der Phoniatrie und Pädaudiologie. Stuttgart, Thieme, 1996, pp 118–125.
  14. Rosanowski F, Eysholdt U: Expert phoniatric assessment of voice adaptation in male to female transsexualism. HNO 1999;47:556–562.
  15. Donald PJ: Voice change surgery in the transsexual. Head Neck Surg 1982;4:433–437.
  16. Wolfe IV, Ratusnik DL, Smith FH, Northrop G: Intonation and fundamental frequency in male-to-female transsexuals. J Speech Hear Disord 1990;55:43–50.
  17. Baker J: A report on alterations to the speaking and singing voices of four women following hormonal therapy with virilising agents. J Voice 1999;13:496–507.
  18. Oswald M: Sprecherziehung bei Transsexuellen: Möglichkeiten und Grenzen. ORL16, Aktuelle Probleme der Otorhinolaryngologie. Bern, Huber,1993, pp 276–279.
  19. Kaplan HI, Sadock BJ: Comprehensive Textbook of Psychiatry. Baltimore, Williams & Wilkins, 1995, pp 1609–1610.
  20. Gross M: Pitch-raising surgery in male-to-female transsexuals. J Voice 1999;13:246–250.
  21. Mahlstedt K, Gross M: Voice adaptive surgery in male-to-female transsexuals. EUFOS Kongress, Berlin. Laryngorhinootologie 2000;78:183.
  22. Yang CY, Palmer AD, Murray KD, Meltzer TR, Cohen JI: Cricothyroid approximation to elevate vocal pitch in male to female transsexuals: Results of surgery. Ann Otol Rhinol Laryngol 2002;111:477–485.
  23. Hacki T: Tonhöhen- und Intensitätsbefunde bei Stimmgeübten: Vergleichende Sprechstimmfeld-, Rufstimmfeld- und Singstimmfeldmessung. HNO 1999;47:809–815.
  24. Dejonkere HP, Bradley P, Clemente P, et al: A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques. Eur Arch Otorhinolaryngol 2001;258:77–82.
  25. The Principles of the International Phonetic Association. London, University College London, 1949.
  26. Friedrich G: Externe Stimmlippenmedialisation: Funktionelle Ergebnisse. Laryngorhinootologie 1998;77:18–26.
  27. de Bruin MD, Coerts MJ, Greven AJ: Speech therapy in the management of male-to-female transsexuals. Folia Phoniatr Logop 2000;52:220–227.
  28. Brown M, Perry A, Cheesman AD, Pring T: Pitch change in male-to-female transsexuals: Has phonosurgery a role to play? Int J Lang Commun Disord 2000;35:129–136.
  29. Mount Kh, Salmon SJ: Changing the vocal characteristics of a postoperative transsexual patient: A longitudinal study. J Commun Disord 1988;21:229–238.
  30. Gunzburger D: Acoustic and perceptual implications of the transsexual voice. Arch Sex Behav 1995;24:339–348.
  31. Spencer LE: Speech characteristics of male-to-female transsexuals: A perceptual and acoustic study. Folia Phoniatr Logop 1988;40:31–42.
  32. Andrews ML, Schmidt PCh: Gender presentation: Perceptual and acoustical analysis of voice. J Voice 1997;11:307–313.
  33. Gefler M P, Schofield KJ: Comparison of acoustic and perceptual measures of voice in male-to-female transsexuals perceived as female versus those perceived as male. J Voice 2000;14:22–33.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50